Concepts of blood transfusion in adults

The Lancet

Volumn 381, Issue 9880, 2013, Pages 1845-1854

  Goodnough, Lawrence T ^a   Levy, Jerrold H ^b   Murphy, Michael F ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANGIONEUROTIC EDEMA; ANTITHROMBIN III DEFICIENCY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; BLOOD FLOW; BLOOD TRANSFUSION; BLOOD VISCOSITY; CARDIOVASCULAR RESPONSE; CLINICAL PROTOCOL; CRYOPRECIPITATE; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEMATOCRIT; HIP FRACTURE; HUMAN; INJURY; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL SOCIETY; OXYGEN TRANSPORT; PARTIAL THROMBOPLASTIN TIME; PLASMA VOLUME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORAX SURGERY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; UPPER GASTROINTESTINAL BLEEDING; VITAMIN K DEFICIENCY;

EID: 84878051147     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60650-9     Document Type: Review

References (109)

1. Healthcare Cost and Utilization Project. HCUP facts and figures 2009. Section 3: inpatient hospital stays by procedure. http://www.hcup-us.ahrq.gov/ reports/factsandfigures/2009/section3-TOC.jsp (accessed April 30, 2013).
2. Morton J, Anastassopoulos KP, Patel S T, et al Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual 2010; 25: 289-96.
3. Goodnough L.T., Shander A. Patient blood management. Anesthesiology 2012; 116: 1367-76.
4. Starr D. Blood: an epic history of medicine and commerce. New York: AA Knopf, 1998.
5. Shander A, Hofmann A, Ozawa S., Theusinger OM, Gombotz H, Spahn DR Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
6. Goodnough L.T., Brecher ME, Kanter M.H., AuBuchon JP Transfusion medicine. Second of two parts-blood conservation. N Engl J Med 1999; 340: 525-33.
7. US Food and Drug Administration Center for Biologics Evaluation and Research. Annual summary for fiscal year 2011. http://www.fda.gov/downloads/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/UCM300764.pdf (accessed Aug 20, 2012).
8. Vamvakas EC. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Transfusion 2013; 53: 888-901.
9. Carlier M, Vo Mai MP, Fauveau L, Ounnoughene N, Sandid I., Renaudier P. Seventeen years of haemovigilance in France: assessment and outlook. Transfusion clinique and biologique 2011; 18: 140-50.
10. Pattakos G, Koch CG, Brizzio M.E., et al Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 2012: 172: 1154-60.
11. Goodnough L.T., Brecher ME, Kanter M.H., AuBuchon JP Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340: 438-47.
12. Sack K. The New York Times. 'Bloodless' lung transplants offer hint at surgery's future. Feb 24, 2013. http://www.nytimes.com/2013/02/25/us/bloodless- lung-transplants-for-jehovahs-witnesses.html?pagewanted=all&-r=0 (accessed Feb 28, 2013)
13. National Blood Authority Australia. Patient blood management guidelines. http://www.nba.gov.au/guidelines/review.html (accessed Oct 15, 2012).
14. Bittencour t.R., Costa J, Lobo J.E., Aguiar FC Consciously transfusion of blood products. Systematic review of indicative factors for blood components infusion's trigger. Rev Bras Anestesiol 2012; 62: 402-10.
15. Goodnough LT, Audet AM Utilization review for red cell transfusions. Are we just going through the motions? Arch Pathol Lab Med 1996; 120: 802-03.
16. Goodnough LT, Despotis GJ, Hogue CW Jr, Ferguson TB Jr. On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 1995; 60: 473-80.
17. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
18. Finch CA, Lenfant C. Oxygen transport in man. N Engl J Med 1972; 286: 407-15.
19. Adams RC, Lundy JS Anesthesia in cases of poor surgical risk: some suggestions for decreasing the risk. Surg Gynecol Obstet 1942; 74: 1011-19.
20. Madjdpour C, Spahn DR, Weiskopf RB Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med 2006; 34 (suppl 5): 102-08.
21. Spence RK, Costabile JP, Young G.S., et al Is hemoglobin level alone a reliable predictor of outcome in the severely anemic surgical patient? Am Surg 1992; 58: 92-95.
22. Carson JL, Noveck H, Berlin J.A., Gould SA Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42: 812-18.
23. van Woerke ns EC, Trouwborst A, van Lanschot JJ. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75: 818-21.
24. Hebert PC, Yetisir E, Martin C., et al Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-34.
25. Parrillo J.E. Journal supplements, anemia management, and evidence-based critical care medicine. Crit Care Med 2001; 29: 139-40.
26. Expert Wor king Group. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997; 156 (suppl 11): 1-24.
27. Hogue CW Jr., Goodnough LT, Monk TG Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998; 38: 924-31.
28. Wu WC, Rathore SS, Wang Y, Radford M.J., Krumholz HM Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-36.
29. Goodnough LT, Bach RG Anemia, transfusion, and mortality. N Engl J Med 2001; 345: 1272-74.
30. Carson JL, Hill S, Carless P., Hebert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16: 187-99.
31. Bracey AW, Radovancevic R, Riggs S.A., et al Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999; 39: 1070-77.
32. Carson JL, Carless PA, Hebert PC Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
33. Hebert PC, Wells G, Blajchman M.A., et al A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
34. Hajjar LA, Vincent JL, Galas F.R., et al Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-67.
35. Carson JL, Terrin ML, Noveck H, et al Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
36. Villanueva C, Colomo A, Bosch A., et al Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
37. Rebulla P, Finazzi G, Marangoni F., et al The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997; 337: 1870-75.
38. Slichter SJ, Kaufman RM, Assmann S.F., et al Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-13.
39. Wandt H, Schaefer-Eckart K, Wendelin K., et al Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012; 380: 1309-16.
40. Stanworth SJ, Estcourt LJ, Powter G, et al A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013; 368: 1771-80.
41. Mudumbai SC, Cronkite R, Hu K.U., et al Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients. Transfusion 2011; 51: 2148-59.
42. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988; 260: 2700-03.
43. Welch HG, Meehan KR, Goodnough LT Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 393-402.
44. American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47.
45. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
46. Innes G. Guidelines for red blood cells and plasma transfusion for adults and children: an emergency physician's overview of the 1997 Canadian blood transfusion guidelines. Part 1: red blood cell transfusion. Canadian Medical Association Expert Working Group. J Emerg Med 1998; 16: 129-31.
47. Simon TL, Alverson DC, AuBuchon J, et al Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998; 122: 130-38.
48. Murphy MF, Wallington TB, Kelsey P, et al Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113: 24-31.
49. British Committee for Standards in Haematology (BCSH). Guideline on the administration of blood components. http://www.bcshguidelines.com/documents/ BCSH-Blood-Admin-addendum-August-2012.pdf (accessed Sept 25, 2012).
50. Australasian Society of Blood Transfusion. Clinical practice guidelines: appropriate use of red blood cells. http://www.nhmrc.health.gov.au (accessed Aug 20, 2012).
51. Ferraris VA, Ferraris SP, Saha S.P., et al Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (suppl 5): 27-86.
52. Ferraris VA, Brown JR, Despotis G.J., et al 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82.
53. Napolitano LM, Kurek S, Luchette F.A., et al Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37: 3124-57.
54. Napolitano LM, Kurek S, Luchette F.A., et al Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma 2009; 67: 1439-42.
55. Shander A, Fink A, Javidroozi M., et al Appropriateness of allogeneic red blood cell transfusion: the International Consensus Conference on Transfusion Outcomes. Transfus Med Rev 2011; 25: 232-46.
56. *. Ann Intern Med 2012; 157: 49-58.
57. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012; 2: 311-16.
58. Rodgers GM 3rd, Becker PS, Blinder M, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 2012; 10: 628-53.
59. Murphy MF, Brozovic B, Murphy W., Ouwehand W, Waters AH Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 1992; 2: 311-18.
60. Cooper ES, Bracey AW, Horvath A.E., et al Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 1994; 271: 777-81.
61. Contreras M. Final statement from the consensus conference on platelet transfusion. Transfusion 1998; 38: 796-97.
62. Schiffer CA, Anderson KC, Bennett C.L., et al Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1519-38.
63. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10-23.
64. Liumbruno G, Bennardello F, Lattanzio A., Piccoli P, Rossetti G. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009; 7: 132-50.
65. National Heart, Lung, and Blood Institute, Center for Drugs and Biologics of the Food and Drug Administration, Office of Medical Applications of Research. Fresh-frozen plasma. Indications and risks. JAMA 1985; 253: 551-53.
66. Contreras M, Ala FA, Greaves M, et al Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 1992; 2: 57-63.
67. O'Shaughnessy D.F., Atterbury C, Bolton Maggs P, et al Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
68. Roback JD, Caldwell S, Carson J., et al Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50: 1227-39.
69. Stover EP, Siegel LC, Parks R, et al Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998; 88: 327-33.
70. Snyder-Ramos S.A., Mohnle P, Weng Y.S., et al The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 2008; 48: 1284-99.
71. Rogers MA, Blumberg N, Saint S., Langa KM, Nallamothu BK Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med 2009; 7: 3 7.
72. Bennett-Guerrero E., Zhao Y, O'Brien SM, et al Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304: 1568-75.
73. Hessel EA 2nd, Levy JH. Guidelines for perioperative blood transfusion and conservation in cardiac surgery: lessons and challenges. Anesth Analg 2010; 111: 1555-59.
74. Likosky DS, FitzGerald DC, Groom R.C., et al Effect of the perioperative blood transfusion and blood conservation in cardiac surgery clinical practice guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. Anesth Analg 2010; 111: 316-23.
75. Goodnough LT, Levy JH Invited commentary. Ann Thorac Surg 2012; 94: 709.
76. Hutton B, Fergusson D, Tinmouth A., McIntyre L, Kmetic A, Hebert PC Transfusion rates vary significantly amongst Canadian medical centres. Can J Anaesth 2005; 52: 581-90.
77. Frank SM, Savage WJ, Rothschild J.A., et al Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012; 117: 99-106.
78. Adams ES, Longhurst CA, Pageler N, Widen E., Franzon D, Cornfield DN Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics 2011; 127: e1112-19.
79. Haspel RL, Uhl L. How do I audit hospital blood product utilization? Transfusion 2012; 52: 227-30.
80. US Department of Health and Human Services. 2007 National Blood Collection and Utilization Survey. http://www.hhs.gov/ash/bloodsafety/2007nbcus- survey.pdf (accessed Aug 21, 2012).
81. Murphy MF, Stanworth SJ, Yazer M. Transfusion practice and safety: current status and possibilities for improvement. Vox Sang 2011; 100: 46-59.
82. Estcourt LJ, Stanworth SJ, Murphy MF Platelet transfusions for patients with haematological malignancies: who needs them? Br J Haematol 2011; 154: 425-40.
83. Estcourt L, Stanworth S, Doree C., et al Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012; 5: CD004269.
84. Cameron B, Rock G, Olberg B., Neurath D. Evaluation of platelet transfusion triggers in a tertiary-care hospital. Transfusion 2007; 47: 206-11.
85. Estcourt LJ, Birchall J, Lowe D., Grant-Casey J, Rowley M, Murphy MF Platelet transfusions in haematology patients: are we using them appropriately? Vox Sang 2012; 103: 284-93.
86. Stanworth SJ, Brunskill SJ, Hyde C.J., McClelland DB, Murphy MF Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-52.
87. Yang L, Stanworth S, Hopewell S., Doree C, Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52: 1673-86.
88. Segal JB, Dzik WH Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-25.
89. Holland LL, Brooks JP Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-39.
90. Stanworth SJ, Grant-Casey J, Lowe D., et al The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51: 62-70.
91. Li G, Rachmale S, Kojicic M., et al Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51: 338-43.
92. Lin Y, Saw CL, Hannach B, Goldman M. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services Transfusion 2012; 52: 567-74.
93. Chapman CE, Stainsby D, Jones H., et al Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-52.
94. Levy JH, Szlam F, Tanaka K.A., Sniecienski RM Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74.
95. Kauvar DS, Lefering R, Wade CE Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60(SUPPL. 6): 3-11.
96. Acosta JA, Yang JC, Winchell R.J., et al Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186: 528-33.
97. Sauaia A, Moore FA, Moore E.E., et al Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38: 185-93.
98. Spinella PC, Holcomb JB Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23: 231-40.
99. Cotton BA, Dossett LA, Au B.K., Nunez TC, Robertson AM, Young PP Room for (performance) improvement: provider-related factors associated with poor outcomes in massive transfusion. J Trauma 2009; 67: 1004-12.
100. Joshi GP. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 2005; 101: 601-05.
101. Como JJ, Dutton RP, Scalea T.M., Edelman BB, Hess JR Blood transfusion rates in the care of acute trauma. Transfusion 2004; 44: 809-13.
102. Moore FA, Nelson T, McKinley B.A., et al Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcome. J Trauma 2008; 64: 1010-23.
103. Holcomb JB, Jenkins D, Rhee P., et al Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307-10.
104. Cotton BA, Gunter OL, Isbell J, et al Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64: 1177-82.
105. Jackman RP, Utter GH, Muench M.O., et al Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 2012; 52: 2533-50.
106. Inaba K, Branco BC, Rhee P, et al Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210: 957-65.
107. Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26: 208-14.
108. Gammon HM, Waters JH, Watt A, Loeb J.M., Donini-Lenhoff A. Developing performance measures for patient blood management. Transfusion 2011; 51: 2500-09.
109. Shander AS, Goodnough LT Blood transfusion as a quality indicator in cardiac surgery. JAMA 2010; 304: 1610-11.